With health. The results of the survey carried out by the Spanish Society of Primary Care Physicians (SEMERGEN) among doctors from all over Spain on the knowledge of biosimilar medicines have brought to the table a problem that many specialists label as "worrying". Up to 58% of family doctors do not know how to define what these types of drugs are.